(Total Views: 499)
Posted On: 02/10/2021 12:38:48 PM
Post# of 145248
RLFTF was hit hard yesterday, no mortality benefit. HGEN share price is down, I can't remember where their trials are, but both the above are given by IV. FDA should be anxious to approve Leronlimab, which also can be a shot actually administered eventually at home. That alone is a huge benefit, add pristine safety and our eIND results and Dr Patterson and andecdotal cases.
If leveraged and coordinating shorting was outlawed, CYDY would be at about $15 IMO today, regardless, it will be there very soon.
If leveraged and coordinating shorting was outlawed, CYDY would be at about $15 IMO today, regardless, it will be there very soon.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)